Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR: Rituximab in TTP
NCT00799773Phase 3Terminated
- Sponsor
- Elevance Health
- Start
- Apr 2009
- Primary completion
- Feb 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in thrombotic thrombocytopenic purpura (TTP), sponsored by Elevance Health. Started Apr 2009; status: terminated.
02
Drugs
rituximab
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT00799773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799773.